11 June 2015 - Deborah Wilkes
Archived
Bayer has agreed to divest its Diabetes Care business, including the Contour portfolio of blood glucose monitoring meters and strips, to Panasonic Healthcare Holdings in a deal worth €1.02 billion (US$1.15 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.